Office-Based Buprenorphine Treatment of Opioid Use Disorder (Online)-Module 4

Module 4 - Additional Resource (Slide Handout)

Pdf Summary

Confidentiality is a crucial aspect of treating patients with substance use disorders, as federal and state regulations restrict the disclosure and use of patient-identifying information. Patient-identifying information includes anything that reveals a person is receiving, has received, or has applied for substance use treatment. There are exceptions to confidentiality, such as internal communications, consent, and situations where disclosure is necessary for medical emergencies or court orders.<br /><br />Medical recordkeeping is another important aspect of treatment. Providers must keep a list of their buprenorphine patients, which cannot exceed a certain number. The medical record should include information about the patient's medications, opioid use disorder diagnosis, treatment plan, and informed consent. It is also important to document any alterations made to the records and ensure proper storage of the records.<br /><br />Office policies and procedures should include necessary resources for referrals and coverage, as well as training for office staff. Financial issues, such as fees and billing, should also be considered and communicated with the patient in advance.<br /><br />In summary, maintaining patient confidentiality, proper medical recordkeeping, and implementing office policies and procedures are essential for providing effective and ethical treatment for patients with opioid use disorders.

Keywords

Confidentiality

Substance use disorders

Patient-identifying information

Federal regulations

State regulations

Medical emergencies

Court orders

Medical recordkeeping

Buprenorphine patients

Treatment plan